BD Announces Results for Third Fisc...(housands except per share data) ...),Health

Three Months Ended June 30,

2008 2007 % Change

REVENUES $1,867,587 $1,631,159 14.5

Cost of products sold 917,362 791,071 16.0

Selling and

administrative 440,588 412,164 6.9

Research and

development 100,071 92,993 7.6

Acquired in-process

research and

development - 7,394 NM

TOTAL OPERATING COSTS

AND EXPENSES 1,458,021 1,303,622 11.8

OPERATING INCOME 409,566 327,537 25.0

Interest income 10,956 11,938 (8.2)

Interest expense (9,017) (11,598) (22.3)

Other income, net (1,285) 1,774 NM

INCOME FROM CONTINUING

OPERATIONS BEFORE

INCOME TAXES 410,220 329,651 24.4

Income tax provision 112,811 89,182 26.5

INCOME FROM CONTINUING

OPERATIONS 297,409 240,469 23.7

(LOSS)/INCOME FROM

DISCONTINUED

OPERATIONS NET OF INCOME

TAX (BENEFIT)/PROVISION

OF $(197) AND $2,704,

RESPECTIVELY (320) 4,340 NM

NET INCOME $297,089 $244,809 21.4

EARNINGS PER SHARE

Basic:

Income from continuing

operations $1.22 $0.98 24.5

Income from

discontinued

operations $- $0.02 NM

Net income $1.22 $1.00 22.0

Diluted:

Income from continuing

operations $1.18 $0.95 24.2

Income from

discontinued

operations $- $0.02 NM

Net income (1) $1.18
'/>"/>